Aberrant silencing of the CpG island-containing human O6-methylguanine DNA methyltransferase gene is associated with the loss of nucleosome-like positioning

Molecular and Cellular Biology

Volumn 17, Issue 10, 1997, Pages 5813-5822

  Patel, Sonal A ^a   Graunke, Dawn M ^a   Pieper, Russell O ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ARTICLE; CHROMATIN STRUCTURE; CONTROLLED STUDY; DNA METHYLATION; GENE EXPRESSION REGULATION; GENE REPRESSION; GLIOMA CELL; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN DNA INTERACTION;

EID: 0030879709     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.10.5813     Document Type: Article

References (44)

1. Antequera, F., and A. Bird. 1993. Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. USA 90:11995-11999.
2. Antequera, F., J. Boyes, and A. Bird. 1990. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62:503-514.
3. Aparicio, O. M., and D. E. Gottschling. 1994. Overcoming telomeric silencing: a trans-activator competes to establish gene expression in a cell cycle-dependent way. Genes Dev. 8:1136-1146.
4. Cockell, M., D. Rhodes, and A. Klug. 1983. Location of primary sites of micrococcal nuclease cleavage on the nucleosome core. J. Mol. Biol. 170: 423-446.
5. 6-methylguanine-DNA-methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells. J. Biol. Chem. 269:17228-17237.
6. 6-methylguanine-DNA-methyltransferase gene in human glioma cell lines. Mol. Cell. Biol. 14:6515-6521.
7. Drew, H. R. 1984. Structural specificities of five commonly used DNA nucleases. J. Mol. Biol. 176:535-557.
8. Erickson, L. C. 1991. The role of O-6 methylguanine DNA methyltransferase (MGMT) in drug resistance and strategies for its inhibition. Semin. Cancer Biol. 2:257-265.
9. Feinberg, A., and B. Vogelstein. 1984. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137:266-267.
10. Gardiner-Garden, M., and M. Frommer. 1987. CpG islands in vertebrate genomes. J. Mol. Biol. 196:261-282.
11. Godde, J. S., S. U. Kass, M. C. Hirst, and A. P. Wolffe. 1996. Nucleosome assembly on methylated CGG triplet repeats in the fragile X mental retardation gene 1 promoter. J. Biol. Chem. 271:24325-24328.
12. Gross, D. S., and W. T. Garrard. 1988. Nuclease hypersensitive sites in chromatin. Annu. Rev. Biochem. 57:159-197.
13. 6-methylguanine-DNA-methyltransferase gene. Nucleic Acids Res. 19:6163-6167.
14. Herman, J. G., F. Lalif, Y. Weng, M. I. Lerman, B. Zbar, S. Liu, D. Samid, D.-S. R. Duan, J. R. Gnarra, W. M. Linehan, and S. B. Baylin. 1994. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA 91:9700-9704.
15. Hershkovitz, M., and A. D. Riggs. 1995. Metaphase chromosome analysis by ligation-mediated PCR: heritable chromatin structure and a comparison of active and inactive X chromosomes. Proc. Natl. Acad. Sci. USA 92:2379-2383.
16. Issa, J.-P. J., Y. L. Ottaviano, P. Celano, S. R. Hamilton, N. E. Davidson, and S. B. Baylin. 1994. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet. 7:536-540.
17. Kass, S. U., J. P. Gaddard, and R. L. P. Adams. 1993. Inactive chromatin spreads from a focus of methylation. Mol. Cell. Biol. 13:7372-7379.
18. Kass, S. U., N. Landsberger, and A. P. Wolffe. 1997. DNA methylation directs a time-dependent repression of transcription initiation. Curr. Biol. 7:157-165.
19. Kovesdi, I., R. Reichel, and J. R. Nevins. 1987. Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control. Proc. Natl. Acad. Sci. USA 84:2180-2184.
20. Lapidus, R. G., A. T. Ferguson, Y. L. Ottaviano, F. F. Parl, H. S. Smith, S. A. Weitzman, S. B. Baylin, J.-P. J. Issa, and N. E. Davidson. 1996. Methylation of estrogen and progesterone receptor gene 5′ CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. Clin. Cancer Res. 2:805-810.
21. Larsen, F., G. Gundersen, R. Lopez, and H. Prydz. 1992. CpG islands as gene markers in the human genome. Genomics 13:1095-1107.
22. Lee, W.-H., R. A. Morton, J. I. Epstein, J. D. Brooks, P. A. Campbell, G. S. Bova, W.-S. Hseih, W. B. Isaacs, and W. G. Nelson. 1994. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. USA 91:11733-11737.
23. Macleod, D., J. Charlton, J. Mullins, and A. P. Bird. 1994. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 8:2282-2292.
24. Martinez-Balbas, M. A., A. Dey, S. K. Rabindran, K. Ozato, and C. Wu. 1995. Displacement of sequence-specific transcription factors from mitotic chromatin. Cell 83:29-38.
25. Maxam, A. M., and W. Gilbert. 1980. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 65:499-560.
26. McArthur, M., and J. O. Thomas. 1996. A preference of histone H1 for methylated DNA. EMBO J. 15:1705-1714.
27. Meehan, R. R., J. D. Lewis, and A. Bird. 1992. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res. 20:5085-5092.
28. Meehan, R. R., J. D. Lewis, S. McKay, E. L. Kleiner, and A. Bird. 1989. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 58:499-507.
29. Miller, M. R., J. J. Castellot, and A. B. Pardee. 1978. A permeable animal cells preparation for studying macromolecular synthesis. DNA synthesis and the role of deoxyribonucleotides in S phase initiation. Biochemistry 17:1073-1080.
30. Nan, X., R. R. Meehan, and A. Bird. 1993. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res. 21:4886-4892.
31. Patel, S. A. Unpublished data.
32. Pfeifer, G. P., and A. D. Riggs. 1991. Chromatin differences between active and inactive X chromosomes revealed by genomic footprinting of permeabilized cells using DNaseI and ligation-mediated PCR. Genes Dev. 5:1102-1113.
33. Pfeifer, G. P., R. L. Tanguay, S. D. Steigerwald, and A. D. Riggs. 1990. In vivo footprint and methylation analysis by PCR-aided genomic sequencing: comparison of active and inactive X chromosomal DNA at the CpG island and promoter of human PGK-1. Genes Dev. 4:1277-1287.
34. 6-methylguanine DNA methyltransferase gene. Cancer Commun. 3:241-253.
35. Pieper, R. O., S. Patel, S. A. Ting, B. W. Futscher, and J. F. Costello. 1996. Methylation of transcription factor binding sites is unnecessary for aberrant silencing of the human MGMT gene. J. Biol. Chem. 271:13916-13924.
36. Qian, X. C., and T. P. Brent. 1996. Delineation of CpG methylation sites in single copies of the MGMT gene promoter. Proc. Am. Assoc. Cancer Res. 37:536.
37. Rideout, W. M., III, P. Eversole-Cire, C. H. Spruck III, C. M. Hustad, G. A. Coetzee, F. A. Gonzales, and P. A. Jones. 1994. Progressive increases in the methylation status and heterochromatinization of the myoD CpG island during oncogenic transformation. Mol. Cell. Biol. 14:6143-6152.
38. Saluz, H. P., and J. P. Jost. 1987. A laboratory guide to sequencing, p. 11-36. Birkheuser, Boston, Mass.
39. Tazi, J., and A. Bird. 1990. Alternative chromatin structure at CpG islands. Cell 60:909-920.
40. Thomas, G. H., and S. C. R. Elgin. 1988. Protein/DNA architecture of the DNaseI hypersensitive region of the Drosophila hsp26 promoter. EMBO J 7:2191-2201.
41. Watts, G. S., and B. W. Futscher. 1996. Hypomethylation of the O6-methylguanine DNA methyltransferase gene body eliminates its expression in a myeloma cell line. Proc. Am. Assoc. Cancer Res. 37:537.
42. Wijnholds, J., and G. Philipsen. 1988. Tissue-specific and steroid-dependent interaction of transcription factors with the oestrogen-induced apoVLDL II promoter in vivo. EMBO. J. 7:2757-2763.
43. Zhang, L., and J. D. Gralla. 1989. In situ nucleoprotein structure at the SV40 major late promoter: melted and wrapped DNA flank the start site. Genes Dev. 3:1814-1822.
44. Zion, M., D. Ben-Yehuda, A. Avraham, O. Cohen, M. Wetzler, D. Melloul, and Y. Ben-Neriah. 1994. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia. Proc. Natl. Acad. Sci. USA 91:10722-10726.